Gilead Sciences Inc (GILD)
110.12
+0.09
(+0.08%)
USD |
NASDAQ |
Feb 21, 15:52
Gilead Sciences Market Cap: 137.24B for Feb. 21, 2025
View 4,000+ Financial Data Types:
Add
Browse
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
Amgen Inc | 163.37B |
Eli Lilly and Co | 785.51B |
Merck & Co Inc | 225.67B |
Pfizer Inc | 149.50B |
Moderna Inc | 13.55B |
Market Cap Related Metrics
PE Ratio | 297.62 |
PS Ratio | 4.798 |
Price to Book Value | 7.131 |
Price to Free Cash Flow | 12.74 |
Price | 110.12 |
Earnings Yield | 0.34% |
Operating PE Ratio | 17.09 |
Normalized PE Ratio | 23.30 |